​

Protara Therapeutics Ownership | Who Owns Protara Therapeutics?

OverviewForecastRevenueFinancialsChart

Protara Therapeutics Ownership Summary

Protara Therapeutics is owned by 107.92% institutional investors, 2.30% insiders. Janus henderson group is the largest institutional shareholder, holding 11.31% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.01% of its assets in Protara Therapeutics shares.

TARA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockProtara Therapeutics107.92%2.30%-10.22%
SectorHealthcare Stocks 50.44%12.38%37.18%
IndustryBiotech Stocks 48.97%12.07%38.96%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group5.21M11.31%$27.15M
Blackrock funding, inc. /de3.66M8.55%$13.99M
Millennium management3.10M7.24%$11.85M
Boxer capital811.63K7.11%$1.69M
Velan capital investment management lp2.84M6.64%$10.87M
Vanguard group2.39M5.66%$12.75M
Vanguard capital management2.30M5.37%$8.79M
Blackstone2.27M5.29%$8.65M
Orbimed advisors2.22M5.18%$8.48M
Sio capital management1.92M4.49%$7.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp2.84M6.62%$10.87M
Acorn capital advisors1.75M1.83%$6.69M
5am venture management1.37M1.82%$5.23M
Sio capital management1.92M1.21%$7.34M
Verdad advisers, lp312.25K1.14%$1.19M
Cvi302.75K0.54%$629.71K
Catalio capital management, lp520.15K0.37%$1.99M
Stempoint capital lp363.67K0.32%$1.58M
Superstring capital management lp121.46K0.29%$463.97K
Integral health asset management1.50M0.23%$5.73M

Top Buyers

HolderShares% AssetsChange
Orbimed advisors2.22M0.16%2.22M
Balyasny asset management1.03M0.00%1.03M
Qube research1.05M0.00%868.51K
Marshall wace, llp701.02K0.00%650.29K
Boxer capital811.63K0.09%602.40K

Top Sellers

HolderShares% AssetsChange
Aigh capital management---1.62M
Driehaus capital management---1.26M
Adage capital partners gp---1.04M
Ra capital management---1.04M
Patient square capital lp---1.03M

New Positions

HolderShares% AssetsChangeValue
Orbimed advisors2.22M0.16%2.22M$8.48M
Balyasny asset management1.03M0.00%1.03M$3.92M
Verdad advisers, lp312.25K1.14%312.25K$1.19M
Cvi302.75K0.54%302.75K$629.71K
Sixth street partners management company157.97K0.00%157.97K$603.45K

Sold Out

HolderChange
Wealth preservation advisors-1.00
Northwestern mutual wealth management-2.00
Root financial partners-5.00
Mai capital management-148.00
Raymond james financial-271.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261212.54%46,228,3251.46%1070.95%781.30%278.00%
Mar 31, 20261124.67%43,683,8169.71%941.07%72-4.00%2450.00%
Dec 31, 202544-46.99%9,253,946-64.69%210.57%28-22.22%10-61.54%
Sep 30, 202533-59.26%6,687,978-77.49%150.32%18-65.38%8-38.46%
Jun 30, 20258128.57%29,714,8836.28%701.49%5365.63%1416.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.66M3.01%116.30K
Vanguard Morn Total Stk Mkt Idx Investor1.66M3.01%116.30K
iShares Russell 2000 ETF1.33M2.42%-23.71K
Vanguard US Total Market Shares ETF616.30K1.74%-
Vanguard Institutional Extnd Mkt Idx Tr586.97K1.07%66.67K
Fidelity Small Cap Index519.25K0.94%11.29K
iShares Russell 2000 Value ETF467.76K0.85%-
Russell 2000 Index Non-Lendable Fund337.79K0.61%-545.00
Russell 2000 Equity Index Fund B337.79K0.61%-545.00
A4Investments SICAV SIF ACCI IlanaA2EURH125.00K0.61%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 29, 2026Shefferman Jesse CEO and PresidentSell$882.16K
Apr 08, 2026Zummo Jacqueline Chief R&D OfficerSell$6.12K
Apr 01, 2026Zummo Jacqueline Chief R&D OfficerSell$118.87K
May 14, 2025Levy Richard S-Buy$63.80K
Mar 26, 2025Zummo Jacqueline Chf Scientific Operations OffSell$96.14K

Insider Transactions Trends

DateBuySell
2026 Q2-3
2026 Q1--
2025 Q21-
2025 Q1-1
2024 Q3-18

TARA Ownership FAQ

Who Owns Protara Therapeutics?

Protara Therapeutics shareholders are primarily institutional investors at 107.92%, followed by 2.30% insiders and -10.22% retail investors. The average institutional ownership in Protara Therapeutics's industry, Biotech Stocks , is 48.97%, which Protara Therapeutics exceeds.

Who owns the most shares of Protara Therapeutics?

Protara Therapeutics’s largest shareholders are Janus henderson group (5.21M shares, 11.31%), Blackrock funding, inc. /de (3.66M shares, 8.55%), and Millennium management (3.1M shares, 7.24%). Together, they hold 27.10% of Protara Therapeutics’s total shares outstanding.

Does Blackrock own Protara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protara Therapeutics.

Who is Protara Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Protara Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.62% of its assets in 2.84M Protara Therapeutics shares, valued at 10.87M$.

Who is the top mutual fund holder of Protara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Protara Therapeutics shares, with 3.01% of its total shares outstanding invested in 1.66M Protara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools